VALNEVA SE ADR reports a Return on Equity (ROE) of -179.78%.

What is VALN's dividend yield?

VALNEVA SE ADR offers a dividend yield of 0.00%.

What is VALN's Deepscope Quality Score?

Deepscope rates VALN's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy VALN?

Deepscope's AI Timing Score for VALN is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does VALN belong to?

VALNEVA SE ADR is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

VALN (NASDAQ) Stock Analysis | VALNEVA SE ADR

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-08 | FS: 2026-03-31)

VALN

VALNEVA SE ADR

US:NASDAQ STOCK Healthcare >> Biotechnology News 92

USD 5.34

-0.15 (-2.65%) Day Change

Watchlist Portfolio Compare Chart

2.41

D/E

-179.8%

ROE

-37.1%

ROA

0.00%

Div Yield

VALNEVA SE ADR
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 5.34 Price -0.15 (-2.65%) Day Change	NEWS SCORE: 92

VALN, the overall quality is not good ( Quality = 31) and the timing to buy is ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	92
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	5.34
PBV / Sector	6.74 / 4.75
Earning Per Share	-1.42

PE / Sector	N/A / 17.65
PEG or PE/Growth / Sector	N/A / 0.52
Average 1M Daily Value	0.26 M GREAT
Average 1W Daily Value	0.15 M GREAT

Timing Factors

14%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

39%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-88.30 / 468.85
NPM Average (%) / Sector	-53.42 / -1,531.69
NPM Change Average (%) / Sector	206.11 / 5,028.65 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-37.07 / 31.69
ROA Average (%) / Sector	-22.70 / -353.18
ROA Change Average (%) / Sector	253.57 / 5,214.65 GREAT
ROE (%) / Sector	-179.78 / 10.58
ROE Average (%) / Sector	-87.86 / 27.64
ROE Change Average (%) / Sector	375.33 / 2,048.88 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 3.97

Registration Details

Analyze Date	2026-06-09 09:40:13
Symbol	VALN
Name	VALNEVA SE ADR
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	94.82 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	519.63 / 9,000.42

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 6 rue Alain Bombard, Saint-Herblain, France, 44800

Phone: 33 2 28 07 37 10

Website: https://valneva.com

Employees: 674

Sector: Healthcare >> Biotechnology

Description: Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and IXCHIQ/ VLA1553, a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also develops VLA15, a vaccine candidate against Borrelia, the bacterium that causes Lyme disease; S4V2, a tetravalent bioconjugate vaccine candidate against shigellosis, a diarrheal infection caused by Shigella bacteria; VLA1601, a vaccine candidate targeting the Zika virus, a mosquito-borne viral disease; VLA1554, a vaccine candidate targeting human metapneumovirus; VLA84, a vaccine candidate targeting the prevention of primary symptomatic clostridium difficile infection; and VLA2112, a vaccine candidate to treat patients with epstein-barr virus. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, France, rest of Europe, and internationally. Valneva SE was founded in 1998 and is based in Saint-Herblain, France.